Abstract: The invention provides colostrum derived stem cell populations, compositions and supplements having antimicrobial properties for enhancing mammalian health and for treating or preventing microbial contamination or infection. Also provided are methods of producing these populations, compositions and supplements from a female mammal in an inflammatory state. Also provided are colostrum derived stem cell populations and method of inducing differentiation into neural cells in neural progenitor medium including mammalian cell culture medium supplemented with casein depleted fraction of whey derived from colostrum. Also provided are neural progenitor medium, population of in vitro differentiated neural cells and pharmaceutical compositions containing same for use in treating neurological disease or disorder.
Type:
Grant
Filed:
September 20, 2019
Date of Patent:
April 1, 2025
Assignee:
MyStem Biotechnologies Inc.
Inventors:
Dilruba Hilal Gul-Uludag, Robert Edward Burrell
Abstract: The invention provides colostrum derived stem cell populations, compositions and supplements having antimicrobial properties for enhancing mammalian health and for treating or preventing microbial contamination or infection. Also provided are methods of producing these populations, compositions and supplements from a female mammal in an inflammatory state. Also provided are colostrum derived stem cell populations and method of inducing differentiation into neural cells in neural progenitor medium including mammalian cell culture medium supplemented with casein depleted fraction of whey derived from colostrum. Also provided are neural progenitor medium, population of in vitro differentiated neural cells and pharmaceutical compositions containing same for use in treating neurological disease or disorder.
Type:
Application
Filed:
September 20, 2019
Publication date:
September 2, 2021
Applicant:
MyStem Biotechnologies Inc.
Inventors:
Dilruba Hilal GUL-ULUDAG, Robert Edward BURRELL